These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 39042779

  • 1. Local-Regional Therapy for Oligometastatic Colorectal Cancer.
    Miller SR, Chang DT.
    Cancer J; ; 30(4):272-279. PubMed ID: 39042779
    [Abstract] [Full Text] [Related]

  • 2. Curable metastatic colorectal cancer.
    Eadens MJ, Grothey A.
    Curr Oncol Rep; 2011 Jun; 13(3):168-76. PubMed ID: 21298372
    [Abstract] [Full Text] [Related]

  • 3. Liver-directed therapy in metastatic colorectal cancer.
    Kelly CM, Kemeny NE.
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):745-758. PubMed ID: 28636427
    [Abstract] [Full Text] [Related]

  • 4. The state of regional therapy in the management of metastatic colorectal cancer to the liver.
    Cho M, Gong J, Fakih M.
    Expert Rev Anticancer Ther; 2016 Aug; 16(2):229-45. PubMed ID: 26652741
    [Abstract] [Full Text] [Related]

  • 5. The role of image-guided therapy in the management of colorectal cancer metastatic disease.
    de Baere T, Tselikas L, Yevich S, Boige V, Deschamps F, Ducreux M, Goere D, Nguyen F, Malka D.
    Eur J Cancer; 2017 Apr; 75():231-242. PubMed ID: 28237869
    [Abstract] [Full Text] [Related]

  • 6. Nonresectional regional therapies for metastatic colorectal cancer to the liver.
    Schlick CJR, Merkow RP, Bentrem DJ.
    J Surg Oncol; 2019 Apr; 119(5):636-641. PubMed ID: 30825217
    [Abstract] [Full Text] [Related]

  • 7. Interventional oncologic approaches to liver metastases.
    Mahnken AH, Pereira PL, de Baère T.
    Radiology; 2013 Feb; 266(2):407-30. PubMed ID: 23362094
    [Abstract] [Full Text] [Related]

  • 8. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C.
    Hepatogastroenterology; 2003 Feb; 50(54):1919-26. PubMed ID: 14696433
    [Abstract] [Full Text] [Related]

  • 9. Surgical and ablative modalities for the treatment of colorectal cancer metastatic to the liver.
    Braccia DP, Heffernan N.
    Clin J Oncol Nurs; 2003 Feb; 7(2):178-84. PubMed ID: 12696214
    [Abstract] [Full Text] [Related]

  • 10. Oligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local Therapies.
    Miller ED, Hitchcock KE, Romesser PB.
    J Gastrointest Cancer; 2023 Dec; 54(4):1116-1127. PubMed ID: 36652155
    [Abstract] [Full Text] [Related]

  • 11. Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
    Pwint TP, Midgley R, Kerr DJ.
    Semin Oncol; 2010 Apr; 37(2):149-59. PubMed ID: 20494707
    [Abstract] [Full Text] [Related]

  • 12. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
    Robin TP, Raben D, Schefter TE.
    Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
    [Abstract] [Full Text] [Related]

  • 13. Stereotactic body radiation therapy for colorectal liver metastases.
    Mohamad I, Barry A, Dawson L, Hosni A.
    Int J Hyperthermia; 2022 Oct; 39(1):611-619. PubMed ID: 35465818
    [Abstract] [Full Text] [Related]

  • 14. Locoregional Liver-Directed Therapies to Treat Unresectable Colorectal Liver Metastases: A Review.
    McFadden NR, Perry LM, Ghalambor TJ, Langan RC, Gholami S.
    Oncology (Williston Park); 2022 Feb 08; 36(2):108-114. PubMed ID: 35180338
    [Abstract] [Full Text] [Related]

  • 15. [End results of combined treatment in metastatic colorectal cancer].
    Polysalov VN, Rutkin IO, Krotova OA, Tlostanova MS.
    Vopr Onkol; 2011 Feb 08; 57(2):265-9. PubMed ID: 21809678
    [No Abstract] [Full Text] [Related]

  • 16. Thermal ablative therapies for secondary hepatic malignancies.
    Mayo SC, Pawlik TM.
    Cancer J; 2010 Feb 08; 16(2):111-7. PubMed ID: 20404607
    [Abstract] [Full Text] [Related]

  • 17. Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study.
    Bower M, Metzger T, Robbins K, Tomalty D, Válek V, Boudný J, Andrasina T, Tatum C, Martin RC.
    HPB (Oxford); 2010 Feb 08; 12(1):31-6. PubMed ID: 20495642
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
    Kimura T, Aikata H, Doi Y, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Katsuta T, Kenjo M, Murakami Y, Awai K, Chayama K, Nagata Y.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818783450. PubMed ID: 29963972
    [Abstract] [Full Text] [Related]

  • 19. Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer.
    You YT, Changchien CR, Huang JS, Ng KK.
    Int J Colorectal Dis; 2006 Jan 01; 21(1):33-7. PubMed ID: 15942741
    [Abstract] [Full Text] [Related]

  • 20. Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.
    Xing M, Kooby DA, El-Rayes BF, Kokabi N, Camacho JC, Kim HS.
    J Surg Oncol; 2014 Aug 01; 110(2):182-96. PubMed ID: 24760444
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.